Search results for

Chris Carter and Simon Reynolds of Davies Collison Cave outline some recent case law and legislative amendments

The Saudi Trade Mark Law sets out the rights of a trade mark owner in Saudi Arabia against infringement. Since the law provides protection against infringement only for registered trade marks in Saudi Arabia, unregistered trade marks cannot be enforced. Administrative and legal actions are available against trade mark infringement in Saudi Arabia.

Malaysia acceded to the Patent Cooperation Treaty (PCT) on August 16 2006. Thereafter, all PCT patent applications filed on or after that date automatically designated Malaysia. In order to enter the national phase in Malaysia, the time limits under PCT Chapters I and II are before the expiration of 30 months from the priority date under Section 780 of Malaysian Patents Act 1983. However, some of these PCT applications have often missed the 30 months deadline to file a request to enter national phase in Malaysia due to the applicant's failure to file the said request on time.

Liu Shen & Associates, Beijing

The Federal Circuit will hear one of its most controversial cases before the end of 2008, as the USPTO appeals a lower district court ruling that its rule changes were unlawful

Frances Chen of Tai E International offers some case reviews with a spotlight on trade mark examination guidelines

Joo Young Moon and Nayoung Kim of Kim & Chang outline some post-amendment protection issues and recent case law

Yali Shao of Liu Shen & Associates outlines the procedures for and implications of the recent possibility of patenting software applications that exist to modify exisiting computer programs

In Common Services Agency v Scottish Information Commissioner, the House of Lords has ruled on the extent to which anonymised information about individuals constitutes "personal data" for the purposes of the Data Protection Act 1998. The decision makes clear that, in keeping with the EU Directive from which the UK's data protection legislation is derived, disclosure of fully anonymised personal information does not amount to processing of personal data which must be carried out in accordance with the data protection principles.

As discussed in Managing IP's March edition, it was becoming increasingly unclear whether method of diagnosis claims were allowable in New Zealand. However, Biosite Incorporated, a recently released decision of the Commissioner of Patents [P31/2007], may assist in clarifying practice in New Zealand.